# A Study of Distal Jejunal-release Dextrose in Obese Participants

Study · id `cardio:ct-nct05385978` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05385978](<https://clinicaltrials.gov/study/NCT05385978>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05385978

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

## Technical summary

Registry record NCT05385978. Randomized; quadruple masking; primary purpose treatment. Start 2022-11-01 (actual); primary completion 2024-11-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT05385978, source copy `cardio:ctgov-nct05385978-2024-10-16`, retrieved 2026-11-18)
- Started: 2022-11-01 (actual) (ClinicalTrials.gov record NCT05385978, source copy `cardio:ctgov-nct05385978-2024-10-16`, retrieved 2026-11-18)
- Primary completion: 2024-11-11 (anticipated) (ClinicalTrials.gov record NCT05385978, source copy `cardio:ctgov-nct05385978-2024-10-16`, retrieved 2026-11-18)
- Completion: 2024-11-11 (anticipated) (ClinicalTrials.gov record NCT05385978, source copy `cardio:ctgov-nct05385978-2024-10-16`, retrieved 2026-11-18)
- Countries: Georgia; Germany; Puerto Rico (ClinicalTrials.gov record NCT05385978, source copy `cardio:ctgov-nct05385978-2024-10-16`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05385978-2024-10-16`, retrieved 2026-11-18)

## The registry's words

- Brief title: A Study of Distal Jejunal-release Dextrose in Obese Participants
- Condition: Obese
- Intervention (Drug): APHD-012
- Intervention (Drug): APHD-012P
- Lead sponsor: Aphaia Pharma US LLC
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

## Provenance

Content hash: 567558c8ebf132fe90be2c94bce3477e20a14a57aa922d90ac1aa6a496173f93
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
